Liver Unit, Department of Medicine, Division of Gastroenterology, University of Calgary, Calgary, AB, Canada.
Liver Int. 2010 Feb;30(2):275-83. doi: 10.1111/j.1478-3231.2009.02153.x. Epub 2009 Oct 27.
The outcomes of pregnancy in patients with cirrhosis are poorly described. Our objective was to assess obstetric outcomes in cirrhotic women and their infants from a population-based perspective.
We analysed the 1993-2005 US Nationwide Inpatient Sample database to identify obstetric hospitalizations among patients with cirrhosis (n=339) and controls matched on age, hospital and year (n=6625). The effect of cirrhosis on maternal and fetal outcomes was evaluated using regression models with adjustment for patient and hospital factors.
Between 1993 and 2005, 114 antepartum and 225 delivery admissions in cirrhotic patients were identified. The estimated mean number of deliveries nationwide increased from 68 to 106 annually between 1993 and 1999 and 2000 and 2005 (P=0.0004). Patients with cirrhosis were more likely to deliver by caesarean [42 vs. 28%; adjusted odds ratio (OR) 1.41; 95% confidence interval (CI) 1.06-1.88]. Maternal (1.8 vs. 0%; P<0.0001) and fetal mortality (5.2 vs. 2.1%; P<0.0001), antepartum admission (OR 2.97; 95% CI 2.24-3.96), and maternal (OR 2.03; 95% CI 1.60-2.57) and fetal complications (OR 3.66; 95% CI 2.74-4.88) were greater among cirrhotic patients than controls. Gestational hypertension, placental abruption and uterovaginal haemorrhage were more common in patients with cirrhosis; their infants had higher rates of prematurity and growth restriction. Hepatic decompensation occurred in 15%, including ascites in 11% and variceal haemorrhage in 5%. In women with decompensation, maternal and fetal mortality were 6 and 12% respectively.
Although rare, pregnancies among women with cirrhosis are increasing. Cirrhotic patients and their infants have an increased risk of obstetric complications, emphasizing the importance of close maternal-fetal monitoring during pregnancy.
肝硬化患者妊娠结局的描述较差。我们的目的是从人群的角度评估肝硬化女性及其婴儿的产科结局。
我们分析了 1993 年至 2005 年美国全国住院患者样本数据库,以确定肝硬化患者(n=339)和年龄、医院和年份匹配的对照组(n=6625)的产科住院情况。使用回归模型评估肝硬化对母婴结局的影响,模型中调整了患者和医院因素。
1993 年至 2005 年间,在肝硬化患者中确定了 114 例产前和 225 例分娩入院。1993 年至 1999 年和 2000 年至 2005 年期间,全国每年估计的分娩量从 68 例增加到 106 例(P=0.0004)。与对照组相比,肝硬化患者更有可能通过剖腹产分娩[42% vs. 28%;调整后的优势比(OR)1.41;95%置信区间(CI)1.06-1.88]。母亲(1.8% vs. 0%;P<0.0001)和胎儿死亡率(5.2% vs. 2.1%;P<0.0001)、产前入院(OR 2.97;95%CI 2.24-3.96)、母亲(OR 2.03;95%CI 1.60-2.57)和胎儿并发症(OR 3.66;95%CI 2.74-4.88)在肝硬化患者中均高于对照组。肝硬化患者更常见妊娠高血压、胎盘早剥和阴道出血;他们的婴儿早产和生长受限的发生率更高。15%的患者发生肝性失代偿,包括 11%的腹水和 5%的静脉曲张出血。在失代偿的女性中,母亲和胎儿死亡率分别为 6%和 12%。
尽管罕见,但患有肝硬化的女性妊娠人数在增加。肝硬化患者及其婴儿发生产科并发症的风险增加,强调妊娠期间密切母婴监测的重要性。